image
Healthcare - Medical - Diagnostics & Research - NYSE - US
$ 192.68
-5.06 %
$ 35 B
Market Cap
26.36
P/E
1. INTRINSIC VALUE

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level.[ Read More ]

The intrinsic value of one IQV stock under the base case scenario is HIDDEN Compared to the current market price of 193 USD, IQVIA Holdings Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart IQV

image
FINANCIALS
15 B REVENUE
3.98%
1.98 B OPERATING INCOME
9.89%
1.36 B NET INCOME
24.47%
2.15 B OPERATING CASH FLOW
-4.91%
-1.6 B INVESTING CASH FLOW
20.09%
-382 M FINANCING CASH FLOW
-16.11%
3.9 B REVENUE
2.15%
550 M OPERATING INCOME
0.36%
285 M NET INCOME
-21.49%
721 M OPERATING CASH FLOW
22.62%
-599 M INVESTING CASH FLOW
-171.04%
-137 M FINANCING CASH FLOW
47.31%
Balance Sheet Decomposition IQVIA Holdings Inc.
image
Current Assets 5.6 B
Cash & Short-Term Investments 1.5 B
Receivables 3.41 B
Other Current Assets 687 M
Non-Current Assets 21.1 B
Long-Term Investments 105 M
PP&E 819 M
Other Non-Current Assets 20.2 B
Current Liabilities 6.49 B
Accounts Payable 709 M
Short-Term Debt 932 M
Other Current Liabilities 4.85 B
Non-Current Liabilities 14.1 B
Long-Term Debt 13.4 B
Other Non-Current Liabilities 672 M
EFFICIENCY
Earnings Waterfall IQVIA Holdings Inc.
image
Revenue 15 B
Cost Of Revenue 9.74 B
Gross Profit 5.24 B
Operating Expenses 2.05 B
Operating Income 1.98 B
Other Expenses 619 M
Net Income 1.36 B
RATIOS
34.96% GROSS MARGIN
34.96%
13.19% OPERATING MARGIN
13.19%
9.06% NET MARGIN
9.06%
22.22% ROE
22.22%
5.09% ROA
5.09%
9.25% ROIC
9.25%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis IQVIA Holdings Inc.
image
Net Income 1.36 B
Depreciation & Amortization 1.12 B
Capital Expenditures -649 M
Stock-Based Compensation 217 M
Change in Working Capital -280 M
Others -161 M
Free Cash Flow 1.5 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets IQVIA Holdings Inc.
image
Wall Street analysts predict an average 1-year price target for IQV of $260 , with forecasts ranging from a low of $175 to a high of $300 .
IQV Lowest Price Target Wall Street Target
175 USD -8.98%
IQV Average Price Target Wall Street Target
260 USD 34.87%
IQV Highest Price Target Wall Street Target
300 USD 55.70%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership IQVIA Holdings Inc.
image
Sold
0-3 MONTHS
320 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
17.1 M USD 4
9-12 MONTHS
2.81 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Aug 27, 2024
Sell 320 K USD
Sherbet Eric
See Remarks
- 1300
246.33 USD
8 months ago
Mar 01, 2024
Sell 4.07 M USD
BOUSBIB ARI
See Remarks
- 16261
250.05 USD
8 months ago
Mar 01, 2024
Sell 3.87 M USD
BOUSBIB ARI
See Remarks
- 15417
251.03 USD
8 months ago
Feb 29, 2024
Sell 2.22 M USD
STAUB W RICHARD
See Remarks
- 8970
247.33 USD
8 months ago
Feb 29, 2024
Sell 760 K USD
STAUB W RICHARD
See Remarks
- 3062
248.33 USD
8 months ago
Feb 29, 2024
Sell 515 K USD
STAUB W RICHARD
See Remarks
- 2068
249.08 USD
8 months ago
Feb 28, 2024
Sell 1.61 M USD
Knightly Kevin C
See Remarks
- 6425
249.94 USD
8 months ago
Feb 28, 2024
Sell 547 K USD
Knightly Kevin C
See Remarks
- 2182
250.83 USD
9 months ago
Feb 16, 2024
Sell 242 K USD
Sherbet Eric
See Remarks
- 1000
241.5 USD
9 months ago
Feb 16, 2024
Sell 804 K USD
Knightly Kevin C
See Remarks
- 3341
240.72 USD
9 months ago
Feb 16, 2024
Sell 1.17 M USD
Knightly Kevin C
See Remarks
- 4867
241.23 USD
9 months ago
Feb 16, 2024
Sell 298 K USD
Knightly Kevin C
See Remarks
- 1239
240.73 USD
9 months ago
Feb 16, 2024
Sell 971 K USD
Knightly Kevin C
See Remarks
- 4021
241.38 USD
11 months ago
Dec 01, 2023
Sell 1.47 M USD
Knightly Kevin C
See Remarks
- 6884
213.72 USD
11 months ago
Dec 01, 2023
Sell 1.25 M USD
Knightly Kevin C
See Remarks
- 5855
214.32 USD
11 months ago
Dec 01, 2023
Sell 81.4 K USD
Knightly Kevin C
See Remarks
- 378
215.29 USD
1 year ago
Sep 19, 2023
Sell 1.55 M USD
Panagos Constantinos
See Remarks
- 7419
208.63 USD
1 year ago
Sep 19, 2023
Sell 4.15 M USD
Panagos Constantinos
See Remarks
- 19898
208.69 USD
1 year ago
Jun 05, 2023
Sell 1.17 M USD
Knightly Kevin C
See Remarks
- 5820
201.89 USD
1 year ago
May 26, 2023
Sell 199 USD
Knightly Kevin C
See Remarks
- 1
198.66 USD
1 year ago
Feb 16, 2023
Sell 378 K USD
Knightly Kevin C
See Remarks
- 1674
225.68 USD
1 year ago
Feb 16, 2023
Sell 625 K USD
Knightly Kevin C
See Remarks
- 2772
225.57 USD
1 year ago
Feb 14, 2023
Sell 230 K USD
Sherbet Eric
See Remarks
- 1000
230 USD
3 years ago
Sep 23, 2021
Bought 1.05 K USD
Bruehlman Ronald E
See Remarks
+ 4
262.82 USD
3 years ago
Oct 25, 2021
Sell 1.03 K USD
Bruehlman Ronald E
See Remarks
- 4
256.93 USD
3 years ago
Jul 20, 2021
Bought 3.19 K USD
Bruehlman Ronald E
See Remarks
+ 13
245.32 USD
2 years ago
Dec 22, 2021
Bought 2.73 M USD
DANHAKL JOHN G
Director
+ 10000
272.93 USD
2 years ago
Nov 29, 2021
Sell 146 M USD
CONNAUGHTON JOHN
Director
- 555094
262.6 USD
3 years ago
Aug 16, 2021
Sell 1.51 M USD
Knightly Kevin C
See Remarks
- 6055
250 USD
3 years ago
Dec 23, 2020
Bought 11.2 M USD
DANHAKL JOHN G
Director
+ 63451
176.95 USD
3 years ago
Nov 24, 2020
Sell 1.66 M USD
Rittenmeyer Ronald A
Director
- 9590
172.96 USD
4 years ago
Nov 16, 2020
Sell 7.11 M USD
Rittenmeyer Ronald A
Director
- 40792
174.35 USD
4 years ago
Oct 12, 2020
Sell 11.8 M USD
BOUSBIB ARI
See Remarks
- 69120
170 USD
4 years ago
Sep 15, 2020
Sell 7.57 M USD
BOUSBIB ARI
See Remarks
- 46080
164.36 USD
4 years ago
Aug 14, 2020
Sell 11.2 M USD
BOUSBIB ARI
See Remarks
- 69120
161.66 USD
4 years ago
Aug 07, 2020
Sell 1.1 M USD
STAUB W RICHARD
See Remarks
- 6884
160.04 USD
4 years ago
Aug 07, 2020
Sell 2.16 M USD
STAUB W RICHARD
See Remarks
- 13483
160.47 USD
4 years ago
Aug 04, 2020
Bought 1.6 M USD
Bruehlman Ronald E
See Remarks
+ 10000
159.94 USD
4 years ago
Jul 28, 2020
Sell 464 M USD
TPG Group Holdings (SBS) Advisors, Inc.
- 2919051
159.12 USD
4 years ago
Jul 22, 2020
Sell 7.37 M USD
BOUSBIB ARI
See Remarks
- 46080
160 USD
4 years ago
Jun 02, 2020
Sell 24.7 M USD
BOUSBIB ARI
See Remarks
- 164877
150.11 USD
4 years ago
Jun 01, 2020
Sell 2.92 M USD
BOUSBIB ARI
See Remarks
- 19443
150 USD
4 years ago
Feb 21, 2020
Sell 358 K USD
Knightly Kevin C
See Remarks
- 2191
163.43 USD
4 years ago
Feb 18, 2020
Sell 2.38 M USD
STAUB W RICHARD
See Remarks
- 14550
163.77 USD
4 years ago
Feb 19, 2020
Sell 939 K USD
Knightly Kevin C
See Remarks
- 5688
165.09 USD
4 years ago
Feb 13, 2020
Sell 492 M USD
TPG Group Holdings (SBS) Advisors, Inc.
Director
- 2996172
164.3 USD
4 years ago
Feb 13, 2020
Sell 116 M USD
CONNAUGHTON JOHN
Director
- 703828
164.3 USD
4 years ago
Jan 31, 2020
Sell 970 K USD
EVANISKO MICHAEL J
Director
- 6250
155.19 USD
4 years ago
Jan 24, 2020
Sell 994 K USD
EVANISKO MICHAEL J
Director
- 6250
159.07 USD
4 years ago
Jan 17, 2020
Sell 1 M USD
EVANISKO MICHAEL J
Director
- 6250
160.76 USD
4 years ago
Jan 10, 2020
Sell 1 M USD
EVANISKO MICHAEL J
Director
- 6250
160.08 USD
4 years ago
Jan 02, 2020
Sell 1.86 M USD
MCDONNELL MICHAEL R
EVP and CFO
- 12000
155.07 USD
4 years ago
Dec 20, 2019
Sell 1.53 M USD
LEONARD JOHN M.
Director
- 10100
151 USD
4 years ago
Dec 20, 2019
Sell 1.57 M USD
LEONARD JOHN M.
Director
- 10100
155 USD
5 years ago
Aug 08, 2019
Sell 410 M USD
TPG Group Holdings (SBS) Advisors, Inc.
Director
- 2616028
156.85 USD
5 years ago
Aug 08, 2019
Sell 89.9 M USD
CONNAUGHTON JOHN
Director
- 573085
156.85 USD
5 years ago
Aug 01, 2019
Sell 678 K USD
Knightly Kevin C
See Remarks
- 4278
158.5 USD
5 years ago
Jul 29, 2019
Sell 1.1 M USD
Knightly Kevin C
See Remarks
- 6945
158.53 USD
5 years ago
Jun 28, 2019
Sell 15.4 M USD
BOUSBIB ARI
See Remarks
- 96000
160 USD
5 years ago
Jun 19, 2019
Sell 14.4 M USD
BOUSBIB ARI
See Remarks
- 96000
150 USD
5 years ago
May 03, 2019
Sell 6.36 M USD
Knightly Kevin C
See Remarks
- 46080
138.06 USD
5 years ago
Apr 01, 2019
Sell 173 K USD
EVANISKO MICHAEL J
Director
- 1193
144.95 USD
5 years ago
Mar 25, 2019
Sell 13.5 M USD
BOUSBIB ARI
See Remarks
- 96000
140.96 USD
5 years ago
Mar 08, 2019
Sell 122 M USD
CONNAUGHTON JOHN
Director
- 868684
140.8 USD
5 years ago
Mar 08, 2019
Sell 569 M USD
TPG Group Holdings (SBS) Advisors, Inc.
Director
- 4044480
140.8 USD
5 years ago
Mar 01, 2019
Sell 170 K USD
EVANISKO MICHAEL J
Director
- 1193
142.71 USD
5 years ago
Feb 20, 2019
Sell 1.53 M USD
STAUB W RICHARD
See Remarks
- 10925
140.46 USD
5 years ago
Feb 20, 2019
Sell 2.26 M USD
STAUB W RICHARD
See Remarks
- 16100
140.6 USD
5 years ago
Feb 14, 2019
Sell 1.06 M USD
Rittenmeyer Ronald A
Director
- 7680
138 USD
5 years ago
Feb 14, 2019
Sell 13.4 M USD
BOUSBIB ARI
See Remarks
- 96000
140 USD
5 years ago
Feb 05, 2019
Sell 499 K USD
Rittenmeyer Ronald A
Director
- 3840
130 USD
5 years ago
Dec 04, 2018
Sell 95 M USD
CONNAUGHTON JOHN
Director
- 767574
123.72 USD
5 years ago
Dec 03, 2018
Sell 1.22 M USD
MCDONNELL MICHAEL R
EVP and CFO
- 9500
128.35 USD
5 years ago
Dec 04, 2018
Sell 442 M USD
TPG Group Holdings (SBS) Advisors, Inc.
Director
- 3573545
123.72 USD
5 years ago
Dec 04, 2018
Sell 196 M USD
CANADA PENSION PLAN INVESTMENT BOARD
10 percent owner
- 1582194
123.72 USD
5 years ago
Dec 04, 2018
Sell 196 M USD
CANADA PENSION PLAN INVESTMENT BOARD
10 percent owner
- 1582194
123.72 USD
6 years ago
Sep 13, 2018
Sell 1.71 M USD
DANHAKL JOHN G
Director
- 13634
125.47 USD
6 years ago
Sep 13, 2018
Sell 31 M USD
DANHAKL JOHN G
Director
- 245783
126.25 USD
6 years ago
Sep 13, 2018
Sell 19.5 M USD
DANHAKL JOHN G
Director
- 153816
126.92 USD
6 years ago
Sep 11, 2018
Sell 4.13 M USD
DANHAKL JOHN G
Director
- 33241
124.37 USD
6 years ago
Sep 11, 2018
Sell 15 M USD
DANHAKL JOHN G
Director
- 120035
124.96 USD
6 years ago
Sep 11, 2018
Sell 37.7 K USD
DANHAKL JOHN G
Director
- 300
125.72 USD
6 years ago
Sep 11, 2018
Sell 114 K USD
DANHAKL JOHN G
Director
- 900
126.89 USD
6 years ago
Sep 12, 2018
Sell 1.39 M USD
DANHAKL JOHN G
Director
- 11319
122.92 USD
6 years ago
Sep 12, 2018
Sell 2.77 M USD
DANHAKL JOHN G
Director
- 22388
123.93 USD
6 years ago
Sep 12, 2018
Sell 22.8 M USD
DANHAKL JOHN G
Director
- 182287
125.04 USD
6 years ago
Sep 07, 2018
Sell 28.1 M USD
DANHAKL JOHN G
Director
- 221900
126.63 USD
6 years ago
Sep 07, 2018
Sell 1.17 M USD
Knightly Kevin C
See Remarks
- 9216
126.46 USD
6 years ago
Sep 07, 2018
Sell 28.1 M USD
DANHAKL JOHN G
Director
- 221900
126.63 USD
6 years ago
Aug 02, 2018
Sell 42.9 K USD
Parks Robert
Sr Vice President, Controller
- 345
124.35 USD
6 years ago
Aug 02, 2018
Sell 65.4 K USD
Parks Robert
Sr Vice President, Controller
- 526
124.34 USD
6 years ago
Jul 26, 2018
Sell 45 M USD
BOUSBIB ARI
See Remarks
- 368640
122.09 USD
6 years ago
Jul 26, 2018
Sell 940 K USD
Rittenmeyer Ronald A
Director
- 7680
122.41 USD
6 years ago
Jun 15, 2018
Sell 9.51 M USD
BOUSBIB ARI
See Remarks
- 92160
103.2 USD
6 years ago
Jun 15, 2018
Sell 319 M USD
CPP Investment Board Private Holdings, Inc.
10 percent owner
- 3097012
103 USD
6 years ago
Jun 15, 2018
Sell 319 M USD
CPP Investment Board Private Holdings, Inc.
10 percent owner
- 3097012
103 USD
6 years ago
Jun 15, 2018
Sell 319 M USD
CPP Investment Board Private Holdings, Inc.
10 percent owner
- 3097012
103 USD
6 years ago
Jun 15, 2018
Sell 692 M USD
TPG Group Holdings (SBS) Advisors, Inc.
Director
- 6716253
103 USD
6 years ago
Jun 15, 2018
Sell 148 M USD
CONNAUGHTON JOHN
Director
- 1441236
103 USD
6 years ago
May 10, 2018
Sell 81.5 K USD
EVANISKO MICHAEL J
Director
- 815
100 USD
6 years ago
Apr 18, 2018
Sell 81.5 K USD
EVANISKO MICHAEL J
Director
- 815
100 USD
6 years ago
Mar 14, 2018
Sell 58.1 K USD
Parks Robert
Sr Vice President, Controller
- 551
105.41 USD
6 years ago
Mar 15, 2018
Sell 36.7 K USD
Parks Robert
Sr Vice President, Controller
- 345
106.24 USD
6 years ago
Mar 05, 2018
Sell 81.6 K USD
EVANISKO MICHAEL J
Director
- 816
100 USD
6 years ago
Feb 26, 2018
Sell 1 M USD
Erlinger III James H
See Remarks
- 10000
100 USD
6 years ago
Feb 16, 2018
Sell 1.27 M USD
GREENBERG JACK M
Director
- 12500
101.64 USD
6 years ago
Feb 16, 2018
Sell 2.54 M USD
GREENBERG JACK M
Director
- 25000
101.63 USD
6 years ago
Jan 17, 2018
Sell 1 M USD
Erlinger III James H
See Remarks
- 10000
99.97 USD
6 years ago
Dec 20, 2017
Sell 1.01 M USD
Erlinger III James H
See Remarks
- 10000
101.21 USD
6 years ago
Dec 01, 2017
Sell 4.69 M USD
BOUSBIB ARI
See Remarks
- 46080
101.79 USD
6 years ago
Nov 30, 2017
Sell 81.6 M USD
DANHAKL JOHN G
Director
- 800276
102 USD
6 years ago
Nov 30, 2017
Sell 553 M USD
TPG Group Holdings (SBS) Advisors, Inc.
director, 10 percent owner:
- 5419971
102 USD
6 years ago
Nov 30, 2017
Sell 119 M USD
CONNAUGHTON JOHN
Director
- 1163191
102 USD
6 years ago
Nov 30, 2017
Sell 255 M USD
CPP Investment Board Private Holdings, Inc.
10 percent owner
- 2499269
102 USD
6 years ago
Nov 30, 2017
Sell 255 M USD
CPP Investment Board Private Holdings, Inc.
10 percent owner
- 2499269
102 USD
6 years ago
Nov 30, 2017
Sell 255 M USD
CPP Investment Board Private Holdings, Inc.
10 percent owner
- 2499269
102 USD
7 years ago
Nov 15, 2017
Sell 1.02 M USD
Erlinger III James H
See Remarks
- 10000
102.17 USD
7 years ago
Nov 06, 2017
Sell 1.99 M USD
GREENBERG JACK M
Director
- 18400
108.07 USD
7 years ago
Nov 06, 2017
Sell 1.62 M USD
GREENBERG JACK M
Director
- 15000
108.06 USD
7 years ago
Nov 01, 2017
Sell 4.98 M USD
BOUSBIB ARI
See Remarks
- 46080
108.14 USD
7 years ago
Oct 18, 2017
Sell 1.01 M USD
Erlinger III James H
See Remarks
- 10000
100.51 USD
7 years ago
Oct 02, 2017
Sell 4.37 M USD
BOUSBIB ARI
See Remarks
- 46080
94.91 USD
7 years ago
Sep 27, 2017
Sell 945 K USD
Erlinger III James H
See Remarks
- 10000
94.52 USD
7 years ago
Sep 19, 2017
Sell 213 M USD
CPP Investment Board Private Holdings, Inc.
10 percent owner
- 2249342
94.87 USD
7 years ago
Sep 19, 2017
Sell 213 M USD
CPP Investment Board Private Holdings, Inc.
10 percent owner
- 2249342
94.87 USD
7 years ago
Sep 19, 2017
Sell 213 M USD
CPP Investment Board Private Holdings, Inc.
10 percent owner
- 2249342
94.87 USD
7 years ago
Sep 19, 2017
Sell 68.3 M USD
DANHAKL JOHN G
Director
- 720248
94.87 USD
7 years ago
Sep 19, 2017
Sell 463 M USD
TPG Group Holdings (SBS) Advisors, Inc.
director, 10 percent owner:
- 4877974
94.87 USD
7 years ago
Sep 19, 2017
Sell 97.8 M USD
CONNAUGHTON JOHN
Director
- 1030429
94.87 USD
7 years ago
Sep 01, 2017
Sell 4.41 M USD
BOUSBIB ARI
See Remarks
- 46080
95.65 USD
7. News
Interpreting IQVIA (IQV) International Revenue Trends Evaluate IQVIA's (IQV) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance. zacks.com - 1 week ago
IQVIA (IQV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 2 weeks ago
IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript IQVIA Holdings Inc. (NYSE:IQV ) Q3 2024 Results Conference Call October 31, 2024 9:00 AM ET Company Participants Kerri Joseph - Senior Vice President, Investor Relations & Treasury Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman - Executive Vice President and Chief Financial Officer Eric Sherbet - Executive Vice President and General Counsel Mike Fedock - Senior Vice President, Financial Planning and Analysis Gustavo Peroni - Senior Director, Investor Relations Conference Call Participants Ann Hynes - Mizuho Shlomo Rosenbaum - Stifel Anne Samuel - JP Morgan Luke Sergott - Barclays Bank Justin Bowers - Deutsche Bank David Windley - Jefferies Elizabeth Anderson - Evercore ISI Michael Cherny – Leerink Partners Operator Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA Third Quarter 2024 Earnings Conference Call. seekingalpha.com - 2 weeks ago
IQVIA Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y Strength in the Research and Development, and Technology and Analytics segments drives IQV's top line in the third quarter of 2024. zacks.com - 2 weeks ago
IQVIA lowers annual revenue forecast amid trial delays Contract research firm IQVIA lowered its annual revenue forecast on Thursday, due to delays in two clinical trials as one of its clients faces logistical challenges. reuters.com - 2 weeks ago
IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates IQVIA Holdings (IQV) came out with quarterly earnings of $2.84 per share, beating the Zacks Consensus Estimate of $2.81 per share. This compares to earnings of $2.49 per share a year ago. zacks.com - 2 weeks ago
IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2024. Third-Quarter 2024 Operating Results Revenue for the third quarter of $3,896 million increased 4.3 percent on a reported basis and 4.2 percent at constant currency, compared to the t. businesswire.com - 2 weeks ago
IQVIA Gears Up to Report Q3 Earnings: Here's What You Should Know IQV's TAS and RD&S revenues are anticipated to have increased, while CSMS revenues are likely to have dipped in the third quarter of 2024. zacks.com - 2 weeks ago
Seeking Clues to IQVIA (IQV) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics Besides Wall Street's top -and-bottom-line estimates for IQVIA (IQV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024. zacks.com - 2 weeks ago
IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 3 weeks ago
IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentatio. businesswire.com - 1 month ago
Here's Why You Should Retain IQVIA Holdings Shares Now While IQV benefits from its market leadership, data-driven innovation and global expansion, it must navigate pricing pressure. zacks.com - 1 month ago
8. Profile Summary

IQVIA Holdings Inc. IQV

image
COUNTRY US
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 35 B
Dividend Yield 0.00%
Description IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Contact 4820 Emperor boulevard, Durham, NC, 27703 https://www.iqvia.com
IPO Date May 9, 2013
Employees 88000
Officers Ms. Keriann Cherofsky Senior Vice President, Corporate Controller & Chief Accounting Officer Dr. Jeffrey A. Spaeder M.D. Senior Vice President, Global Chief Medical & Scientific Officer Ms. Andrea Spannheimer Global Head of Real-World & Late Phase Research Kerri Joseph SVice President of Investment Relation & Treasury Dr. Cynthia L. Verst President of Design & Delivery Innovation Ms. Trudy Stein Chief Human Resources Officer & Executive Vice President Mr. Ari Bousbib Chief Executive Officer & Chairman Mr. W. Richard Staub III President of Research & Development Solutions Mr. Jim Berkshire Executive Vice President of Global Technology & Operations Mr. Ronald E. Bruehlman Executive Vice President & Chief Financial Officer